Thursday, March 10, 2011

Migraine drug increases birth defects

 

Taking a migraine and epilepsy drug known as topiramate by pregnant women can increase the risk of developing oral birth defects in the unborn, US federal agency warns.

The Food and Drug Administration (FDA) announced that expectant mothers who use topiramate (Topamax) are about 20 times more likely to have their infants develop cleft lips or cleft palate deformities.

PressTV

No comments:

Post a Comment

DISCLAIMER

Know4LIFE's YES News is a blog designed to bring alternative news and information that is relevant to Youth and their Parents. As such, any and all views and opinions expressed herein, regardless of authorship, do not represent the views or opinions of any author's employer or people, institutions or organizations that the author may or may not be related to or affiliated with unless explicitly stated otherwise. YES News includes links to other sites/blogs operated by third parties. These links are provided for convenience and informational purposes only. As such, the information, opinions, products, and/or services contained therein do not reflect the views and opinions of or represent endorsement Know4LIFE or YES Media. All images that appear on YES News are under the copyright of their respective owners. Know4LIFE's YES News does not claim credit for any image unless explicitly stated. If you own the rights to any image appearing on YES News and do not wish for it to appear, please notify Know4LIFE immediately and the image shall be promptly removed.